MedTrace Logo

Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients

NCT02482974 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2016-12-21

No results posted yet for this study

Summary

This study aims to determine the safety and efficacy of conversion of sirolimus to everolimus in the maintenance treatment of LT recipients. Patients will be monitored every 12 weeks after the switch of treatment for 48 weeks. The laboratory tests including hematological, renal, hepatic, and metabolic parameters will be performed at each visit. Twenty-four-hour urine creatinine clearance and proteinuria will be determined from a 24-hour urine collection at baseline and week 48.

Conditions

  • Liver Transplant Recipients

Sponsors & Collaborators

  • Ege University

    lead OTHER

Principal Investigators

  • Ilker Turan, M.D. · Ege University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02482974 on ClinicalTrials.gov